Metacognitive Training for Older Adults
Feasibility, Acceptance and Efficacy of Metacognitive Training-Silver BeWell in Older Adults
This study is testing a 10-week program to help older adults with depression by improving their thinking and emotional skills in community settings.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg) |
| Trial ID | NCT06312241 on ClinicalTrials.gov |
What this trial studies
This study examines the feasibility, acceptance, and efficacy of Metacognitive Training-Silver (MCT-Silver) BeWell among older adults aged 60 and above, delivered in community settings such as social-psychiatric centers and nursing homes. The intervention aims to improve insight and reduce negative cognitive beliefs and unhelpful behaviors associated with depression. By utilizing a standardized, cognitive-behavioral therapy-based group approach, the study seeks to address the lack of effective, low-threshold interventions for older adults experiencing depressive symptoms. Participants will engage in a 10-week program designed to enhance their emotional regulation strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 60 years and older who can communicate in German and are willing to participate in a group intervention.
Not a fit: Patients with acute suicidality or severe cognitive impairments such as dementia will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental well-being and quality of life for older adults suffering from depressive symptoms.
How similar studies have performed: Previous studies have shown success with similar cognitive-behavioral approaches in younger populations, but this specific application in older adults is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent * Age 60 years or older * Sufficient command of the German language * Willingness to participate in intervention over a period of 10 weeks (participants who do not attend the intervention, but complete questionnaires will also be included in the analysis) * Visual and auditory acuity adequate for participation in group sessions * Ability to participate in the group setting (ability to participate in the group setting will be assessed during a screening interview (e.g., adequate social skills)). Exclusion Criteria: * Acute suicidality as assessed by BDI-II Item 9 * Dementia (MMSE \< 24) or evidence of severe organic brain dysfunction
Where this trial is running
Hamburg
- University Medical Center Hamburg-Eppendorf — Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Brooke Viertel, PhD — Universitätsklinikum Hamburg-Eppendorf
- Study coordinator: Brooke Viertel, PhD
- Email: b.viertel@uke.de
- Phone: 040 7410 24014
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.